I agree upmarket with your assessment as the valuation process in itself should provide opportunities for aoh to re-rate. I am not hung up on what valuation arrived at which could been some good input on here on, as even low end of valuation range offers considerable upside from here. I also don't see a lot of downside risk against the potential upside return.
- Forums
- ASX - By Stock
- AOH
- who pays/selects an independent valuer ?
who pays/selects an independent valuer ?, page-57
Featured News
Add AOH (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online